Background: The reported incidence of second malignant neoplasms (SMN) in long-term survivors of Hodgkin lymphoma (HL) is derived from patients treated with outdated radiation therapy (RT) techniques.

EQS-News: Heidelberg Pharma AG / Key word(s): StudyHeidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma 27.05.2025 / 08:07 ...

Background: The PD-1 inhibitor pembrolizumab is approved globally for the treatment of multiple cancers, including relapsed or refractory (R/R) classic Hodgkin lymphoma (cHL) and R/R primary ...

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) occurring in patients with advanced B-cell lymphoma (BCL).

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

This trial started in 2014 and these results were published in 2016. Researchers wanted to find out whether nivolumab helped people with Hodgkin lymphoma that had come back after a stem cell ...

Mantle cell lymphoma is a rare, aggressive type of non-Hodgkin lymphoma arising from malignant B cells in the mantle zone of lymph nodes. It accounts for about 5% of lymphoma cases, is more common ...

Mantle cell lymphoma is one of about 60 sub-types of non-Hodgkin lymphoma, the Cancer Council's website says. Szubanski says she is surrounded by "beautiful friends and family and an incredible ...

Mantle cell lymphoma is a rare type of B cell non-Hodgkin lymphoma. It is a cancer of the lymphatic system – part of the immune system which produces immune cells and protects the body from ...

Non-Hodgkin Lymphoma Perspective Are We on the Brink of Redefining Follicular Lymphoma? A young specialist explores a paradigm shift in the cyclical 'treat, respond, relapse, ...

Mantle cell lymphoma is a type of blood cancer that begins in the lymphatic system. It is one of about 60 subtypes of non-Hodgkin lymphoma, according to the Cancer Council's website .

Follicular lymphoma is a form of non-Hodgkin lymphoma. It’s usually slow-growing and responds well to treatment but is difficult to cure. Since it is a slow-moving cancer, doctors and patients ...